Posted on

Election Notification

From the Desk of the President-Elect, Urological Society of India

Dear Members,

Greetings from USI

As per the provisions under Section 11 of the revised Constitution of Urological Society of India, notification is hereby given for USI Elections 2021 for the following posts:

President Elect – One

Council Member North Zone – One

Council Member West Zone –  One

Council Member East Zone –  One

Council Member South Zone – Two

The elections would be held through Electronic Voting (E-Voting).

The Election schedule is as follows:

Last Date for submission of Application:  15 October 2020, 5 PM

Last Date for withdrawal of application:  31st October 2020, 5 PM

Scrutiny and announcement of Candidates: 15 November 2020, 5 PM

“On-line” Voting Dates will be announced

The dates and mode of voting will be intimated in due course.

Nominations are invited on the prescribed form, which is attached here, and can also be downloaded here.

Completed nomination form, duly filled in the prescribed format, proposed and seconded by two FULL members of USI, must reach the central office before 5 PM of 15 October 2020. While sending the form, please write in bold letters on the envelope: “Nomination for USI Election 2021”. The soft copy of the same along with the bio data must be sent by email to the Election Officer at mallikuro7@gmail.com and USI Central Office at usicentraloffice1@gmail.com.

Address for mailing the hard copy of nomination form:

Urological Society of India

19, First Floor,
Near Patel Nagar Metro Station,
Opposite Metro Pillar No. 195,
South Patel Nagar,
New Delhi 110008.

Note:

  • The applicants are required to submit a brief CV (maximum of 300 words) & a recent photograph along with the nomination form for publication in the USI Newsletter.
  • Candidates contesting for the post of President-Elect are requested to provide the details of USI Council membership tenure in the nomination form. Those who are applying for these posts should have completed one full term (2 Years) as a council member in the national body prior to declaration of results. 
  • Candidates contesting for the post of USI Council membership are requested to give the details of the post held and the tenure as office bearer in the respective Zonal Chapters. Those contesting for the post of council members should have completed one full term (2 Years) in the zonal chapter prior to declaration of results. 
  • Any member holding an executive post in the national body or the zonal chapter or any subsidiaries of USI are not eligible to contest for the elections.
  • Any failure of compliance on any of the guidelines will automatically lead to disqualification.
  • As per the decision of the USI Council in July 2019, the ban on canvassing has been revoked.
  • The result of the voting (including the vote-count) will be declared by the election officer after completion of all the formalities.

With best regards,

Prof (Dr) Mallikarjuna C
President-Elect & Election Officer, 
Urological Society of India
Managing Director
Asian Institute of Nephrology and Urology
Hyderabad
09849055699
mallikuro7@gmail.com 

Posted on

Simulation in Urology Webinar

20th September 2020 – 5.40 pm IST

The first of its kind simulation in urology webinar organized by the urology Society of India and the Indian school of urology

20th September 2020 would be a day on which the first of its kind webinar on simulation in urology would be witnessed. It has been planned by the Urology Society of India and the Indian school of urology under the guidance of president Dr Anant Kumar and secretary Dr TP Rajeev,  ISU president Dr Rajiv Sood and co Chairman Dr Arun Chawla.

Eminent urologist and innovator Dr Ashish Rawandale- Patil would be the chief convener of the session.

Simulation is becoming the keystone for learning practical skills in urology in recent times. Indian simulation in urology has seen itself grow from scratch from the days when the concept of simulation was non existent in the country to the present day scenario of a well structured nation wide simulation program. It all started with a table discussion at the Urology Society of India council meeting in 2016 and slowly grew to a scale where more than 500 delegates trained in the simulation arena at the Kochi USICON 2020. The USI now conducts such simulation programs four times a year and has evolved from sessions for training the postgraduates, to sessions for training the consultants and trainers.

The USI is extremely happy to have 6 international and 28 national faculties to deliberate on this interesting topic during the webinar.

This extensive webinar of three hours would cover all the aspects of simulation from box simulators to high fidelity simulators, to homegrown innovations which have reached the international forums. Role of a good curriculum, role of various governing bodies, educational Institutes,  teachers, students and simulation industry would be covered. Debates and Star talks punctuate the webinar at various salient junctions. Various Indian origin simulators would also be presented during the webinar.

We welcome you all, to this never seen before extravaganza of simulation: Sunday 20th September 5:40 PM IST.

Long live USI

Posted on

Diagnostic modalities in Ca Prostate: Do we have too many or too less?

13th September, 2020 1000 – 1300 hrs

Prostate carcinoma continues to be an enigma for uro-oncologists the world over. With the varied presentations and the myriad of diagnostic modalities available, and an ever increasing molecular and genomic markers, we need to revisit the appropriate diagnostic workup. How do the genomic biomarkers add to the management of prostate cancer, whether a multi parametric MRI is needed for all patients or a simple MRI would suffice? Should we go in for a whole body PSMA PET scan or should we follow the west and stick to bone scans? When should we get a computed tomography scan done? Where have we reached in the field of radiomics and genomics of prostate cancer? Answer to all these questions and many more, with discussions with experts, their opinions and practices would be available in a webinar dedicated exclusively to the diagnostic modalities of carcinoma prostate. Also join us for the “Star Talk” of the day, to be delivered by Dr. Ash Tewari, from Mount Sinai, New York where he will talk about combining imaging and bio markers to better understand prostate cancer. So join us this coming Sunday morning for an academic feast which promises to decipher the enigma that prostate cancer is.

Tushar Aditya Narain, Convenor

Posted on

Grafts and Flaps in Urology Webinar

Graft and Flaps in Urology Webinar
Graft and Flaps in Urology Webinar

6th September, 1000-1315 Hrs

Reconstructive urology is one of the challenging subspecialties. It is a combination of knowledge of anatomy & physiology of healing along with ingenuity & art. Reconstruction indeed is all about grafts and flaps; which are really the nuts and bolts of reconstructive urology. When naturally similar tissues cannot be brought together due to the damage as a result of trauma, disease, or congenital cause the grafts and flaps are indispensable.
This symposium brings you the wholesome package beginning with the basics of grafts and flaps and their healing. It takes you through common and uncommon grafts and flaps in Urology. Very importantly it also refers to the etio-pathogenesis of failure and measures to prevent and also to treat them. A new frontier in grafts-Tissue Engineering brings a cutting-edge knowledge of modern times.
A section is devoted to specific and broad areas such as female urethral reconstruction pediatric and hypospadias and upper tract. A comparative analysis is then being done between grafts and flaps with respect to their application.
The webinar has a very interesting set of challenging cases during the illustrative case discussion section. A full hour is specifically dedicated to this sought-after section. We are trying to accommodate as many cases as possible. The presenters will challenge the expert panelists.
Your active participation with questions and comments in “CHAT” are very welcome.
We look forward to interacting with you on Sunday 6th September 2020 from 10 a.m. to 1:15 p.m.
Do join us in Big Numbers.

Posted on

Subspecialty in Urology Webinar

USI ISU webinar on subspecialty in Urology will be held on 23rd August 2020.

In India, organised Urology practice started around 1960 by a group of
surgeons interested in Urology. The era between the years 1960-80 was an era of
struggle for Urology, when Urologists had to compete with General Surgeons.The
decades from 1980-2000 saw the stabilisation of Urology as a standalone speciality.
After year 2000, sub-specialisation practice started in Urology and some institutions
started fellowships in Urology.
India is a vast country of 130 billion population and at present, the ratio of
Urologists is 1:5 lac population. Most Urologists are practicing in tier 1 and 2 cities.
The question then arises whether to provide basic Urology care for such a large
population or develop the field further by subspecialisation practice.
There are so many unanswered questions like – Who should do
subspecialisation? In which subspecialty? What should be the duration of
fellowships? When to do subspecialisation? Where to practice after
subspecialisation ? Should work in which city? Should work as solo practice orin
group practice?Should practice in subspeciality alone or combined with Urology
practice? Is subspecialty practice alone financially viable.
We will discuss all these issues as per our survey responses and try to find
answers in our Webinar on 23rd August, 2020 between 10.30am –1.15pm. Please
join.

Posted on

USICON 2021

Due to COVID pandemic the conference has been shifted to 8th – 11th April’2021

USICON 2021 at Ahmedabad awaits you for an academic feast. Ahmedabad (pronounced as Amdavad in Gujarati) is the largest city and former capital of the Indian state of Gujarat. It is the administrative headquarters of the Ahmadabad district and the seat of the Gujarat High Court. Ahmedabad’s population of 5,633,927 (as per 2011 population census) makes it the fifth-most populous city in India, and the encompassing urban agglomeration population estimated at 6,357,693 is seventh-most populous in India. Ahmadabad is located on the banks of the Sabarmati River, 30 km (19 mi) from the state capital Gandhinagar, which is its twin city.


Ahmedabad has emerged as an important economic and industrial hub in India. It is the second-largest producer of cotton in India, and its stock exchange is the country’s second oldest. Cricket is a popular sport in Ahmedabad, which houses the 54,000-seat Sardar Patel Stadium. The effects of liberalization of the Indian economy have energized the city’s economy towards tertiary sector activities such as commerce, communication, and construction. Ahmedabad’s increasing population has resulted in an increase in the construction and housing industries resulting in the recent development of skyscrapers.

Organising secretariat
Shyam Urosurgical Hospital,
4th-floor, Viva complex,
Opposite Parimal Garden, Ellisbridge,
Ahmedabad- 380006, Gujarat, India,
Ph: 079-26469846, 079- 26466700
Email: usiconaua2021@gmail.com

Register for USICON 2021
USICON 2021 Website

Posted on

USI ISU AUA Program

15th August 2020

1630 – 1700 IST

Opening Address : Dr Rajeev Sood, Chairman ISU( 3 mins )
Address by Dr Anant Kumar, President, USI ( 3 mins )
Report by Dr Rajeev T P, Hon Secretary, USI ( 3 mins )
Address by Dr John Denstedt, Secretary, AUA ( 3 mins )
Address by Dr Aseem Shukla ( 3 mins )
Invocation and inauguration ( 5 mins )
Vote of thanks by Dr Arun Chawla, Co Chairman, ISU ( 3 mins )

Session I: Infertility 1700 – 1930 HRS IST
Moderator : Dr S S Vasan

1700 – 1730 IST Penile Implants: What I’ve Learned from 1000 cases – Dr Tobias Kohler
1730 – 1800 IST Supra-physiologic testosterone supplementation: Do body builders know something we don’t? – Dr Tobias Kohler
1800 – 1830 IST Canaries, Giraffes and a little bit of ZEN: Origins and Treatment of ED through vascular mechanisms – – Dr Tobias Kohler
30 – 1900 IST Nothing Beats a TURP? –– Dr Tobias Kohler
1900 – 1920 IST LIVE Q&A via Zoom
1920 – 1930 IST Expert comments :Dr Rupin Shah, Dr Datteswar Hota

Moderator :Dr Anil Takwani
1930 – 2000 IST Antenatal hydronephrosis: A step-wise approach –Dr Aseem Shukla
2000 – 2030 IST Cryptorchidism: What to Do (and not to do)–Dr Aseem Shukla
2030 – 2100 IST The valve bladder syndrome: The end stage of Posterior urethral valves –Dr Aseem Shukla
2100 – 2130 IST UTI and Reflux: A contemporary understanding –Dr Aseem Shukla
2130 – 2150 IST LIVE Q&A via Zoom
Expert comments :Dr M S Ansari, Dr Chandra Singh

16th August 2020

Session Female Urology 1700 – 1945 hrs IST

Moderator : Dr Arun Chawla

1700 – 1730 IST Midurethral Slings – Current Controversies –Dr Priyanka Gupta
1730 – 1800 IST The Pelvic Floor – Anatomy, treatment of pelvic floor dysfunction –Dr Priyanka Gupta
1800 – 1830 IST Evaluation and management of pelvic organ prolapse –Dr Priyanka Gupta
1830 – 1900 IST Voiding Dysfunction –Dr Priyanka Gupta
1900 – 1920 IST LIVE Q&A via Zoom
1920 – 1930 IST Expert comments : Dr Aneesh Srivastava, Dr Sanjay Sinha

Concluding comments :Dr Rajeev T P , Hon Secretary, USI
Dr Aseem Shukla, Assistant Secretary, AUA

Posted on

Webinar on Testicular and Penile Cancer

The increase in Urologists and centres dedicated to oncology in India in the last decade has been a welcome change. While this is already translating into better clinical and operative management of patients with Urological cancers, it can be further extended to meaningful research eventually contributing to better patient outcome. Globally Penile and Testicular cancer are classified as rare genitourinary cancers. India has a relatively higher incidence of penile cancer compared to that in many other developed nations. Rare cancers suffer from lack of strong evidence in various aspects of its management. One way of generating evidence is to conduct multi institutional studies or collaborative studies. If Indian centres routinely managing these cancers join hands, we would be able to fill the evidence gaps that are glaring at us.

This webinar is an attempt to highlight the missing links in understanding of penile and testicular cancers. Further, USI intends to discuss its vision and the pathways and challenges in conducting national and international collaborative studies which could be very relevant to these cancers. We are fortunate to have the company of three distinguished International faculties with immense experience in translational and clinical research and collaborative studies related to these two cancers.  The increase in Urologists and centres dedicated to oncology in India in the last decade has been a welcome change. While this is already translating into better clinical and operative management of patients with Urological cancers, it can be further extended to meaningful research eventually contributing to better patient outcome. Globally Penile and Testicular cancer are classified as rare genitourinary cancers. India has a relatively higher incidence of penile cancer compared to that in many other developed nations. Rare cancers suffer from lack of strong evidence in various aspects of its management. One way of generating evidence is to conduct multi institutional studies or collaborative studies. If Indian centres routinely managing these cancers join hands, we would be able to fill the evidence gaps that are glaring at us.

This webinar is an attempt to highlight the missing links in understanding of penile and testicular cancers. Further, USI intends to discuss its vision and the pathways and challenges in conducting national and international collaborative studies which could be very relevant to these cancers. We are fortunate to have the company of three distinguished International faculties with immense experience in translational and clinical research and collaborative studies related to these two cancers.   

Posted on

USI TV Video Library – Submission Guidelines

USI Social Media/Website Video Submission Guidelines

Purpose: 

To make available Classical and New surgical techniques available to the peers in the community

Gradually building a video academy involving all surgical techniques related to Urological Speciality for better learning of others

Type of Videos: 

Classic Surgical Techniques/New Techniques covering entire procedure- Endourological/Laparoscopic/Robotic/Open Surgery

Length of Video: 

Maximum up to 15 minutes in duration. 

Submission of longer videos (if felt by author for a surgical Technique) requires prior permission.

Video Specifications:

  • The video must include audio narration explaining the procedure along with some text to mention critical steps/technique in the video 
  • Text and audio in the video must be in English. 
  • Audio must include narration in clear, grammatically correct English.
  • Videos must be clear, without excessive camera movement and in focus. 
  • Grainy, blurry videos will not be accepted. 
  • Editing must involve smooth transitions.
  • High-Definition (HD) video is preferred
  • Any patient-identifiable information in Radiographs and other images must not be included
  • Few PowerPoint slides may be included in the video to include details of patient history/clinical/laboratory findings/data and analysis. 
  • Videos that are only a PowerPoint slideshow will not be considered.
  • Conclusions must be related to the submission and must not be overstated

Authors: Maximum up to 4

Accepted video formats: 

  • Windows Media Video (WMV)
  • MPEG (MPG, MPEG, MP4)
  • Audio Video Interleave (AVI)
  • QuickTime (MOV)

Preparation of Word File to Accompany Video: A Word document must be provided that contains the following:

  • Full video title
  • Exact running time of video
  • All contributing authors
  • All authors’ affiliations and email addresses
  • Author Disclosure statement
  • Potential conflict of Interest (if any)/Any commercial Association
  • Patient Consent Statement- Authors must state, “Author(s) have received and archived patient consent for video recording/publication in advance of video recording of procedure.” 

Review Process:

It is under the discretion of Review Team to accept or Reject without explaining the reasons.

Post Acceptance Process:

Once accepted Video will be intimated to the author and circulated on various USI Platforms (Facebook, Twitter, Telegram and USI webpage), mentioning name(s) of the author.

Video is only for USI online Platforms and does not bear any indexation

Submission Portal: Will be created soon